共 122 条
[1]
Kim KB(2014)PFS as a surrogate for overall survival in metastatic melanoma Lancet Oncol 15 246-248
[2]
Stupp R(2009)Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 126-128
[3]
Roila F(2009)IDH1 and IDH2 mutations in gliomas N Engl J Med 360 765-773
[4]
Yan H(2005)MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 997-1003
[5]
Parsons DW(2008)Malignant gliomas in adults N Engl J Med 359 492-507
[6]
Jin G(2016)Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme Neurol Sci 37 23-29
[7]
Hegi ME(2005)MRI in treatment of adult gliomas Lancet Oncol 6 167-175
[8]
Diserens AC(2012)Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study J Neurooncol 108 491-498
[9]
Gorlia T(2004)Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-n-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume J Magn Reson Imaging 19 546-554
[10]
Wen PY(2006)Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis Radiology 241 839-846